Biohaven flunks phase 2 depression trial, adding to concerns for pivotal epilepsy readout
Biohaven flunks phase 2 depression trial, adding to concerns for pivotal epilepsy readout
Body unavailable. Use the original source.
Biohaven flunks phase 2 depression trial, adding to concerns for pivotal epilepsy readout
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.